XIAP and renal cell carcinoma: GSK-3β is a positive regulator of nuclear factor kappa beta (NF-κB) activity that increases its downstream anti-apoptotic molecules, B-cell lymphoma factor 2 (Bcl-2) and X-linked inhibitor of apoptosis protein (XIAP), which increase RCC cell survival and chemoresistance [38].